Page last updated: 2024-08-23

idarubicin and Neuroectodermal Tumors, Primitive, Peripheral

idarubicin has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arndt, CA; Krailo, MD; Liu-Mares, W; Reaman, GH; Scheithauer, B; Steinherz, L	1

Trials

1 trial(s) available for idarubicin and Neuroectodermal Tumors, Primitive, Peripheral

Article	Year
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer, 1998, Aug-15, Volume: 83, Issue:4 Topics: Adolescent; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Infusions, Intravenous; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive, Peripheral	1998

Article

Year

A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.

Cancer, 1998, Aug-15, Volume: 83, Issue:4

Topics: Adolescent; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Infusions, Intravenous; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive, Peripheral

1998